207 related articles for article (PubMed ID: 19800945)
1. Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.
Pickens CL; Adams-Deutsch T; Nair SG; Navarre BM; Heilig M; Shaham Y
Neuroscience; 2009 Dec; 164(4):1398-406. PubMed ID: 19800945
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
Britton KT; Akwa Y; Spina MG; Koob GF
Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y Reduces Social Fear in Male Mice: Involvement of Y1 and Y2 Receptors in the Dorsolateral Septum and Central Amygdala.
Kornhuber J; Zoicas I
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576305
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors.
Tebbe JJ; Mronga S; Schäfer MK; Rüter J; Kobelt P; Mönnikes H
Am J Physiol Gastrointest Liver Physiol; 2003 Dec; 285(6):G1075-83. PubMed ID: 12855401
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.
Kornhuber J; Zoicas I
J Psychopharmacol; 2019 Dec; 33(12):1533-1539. PubMed ID: 31328614
[TBL] [Abstract][Full Text] [Related]
6. Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors.
Giesbrecht CJ; Mackay JP; Silveira HB; Urban JH; Colmers WF
J Neurosci; 2010 Dec; 30(50):16970-82. PubMed ID: 21159967
[TBL] [Abstract][Full Text] [Related]
7. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis.
Kash TL; Winder DG
Neuropharmacology; 2006 Oct; 51(5):1013-22. PubMed ID: 16904135
[TBL] [Abstract][Full Text] [Related]
9. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
[TBL] [Abstract][Full Text] [Related]
10. Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats.
Ide S; Hara T; Ohno A; Tamano R; Koseki K; Naka T; Maruyama C; Kaneda K; Yoshioka M; Minami M
J Neurosci; 2013 Apr; 33(14):5881-94. PubMed ID: 23554470
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y in the paraventricular nucleus of the hypothalamus stimulates colonic transit by peripheral cholinergic and central CRF pathways.
Mönnikes H; Tebbe J; Bauer C; Grote C; Arnold R
Neurogastroenterol Motil; 2000 Aug; 12(4):343-52. PubMed ID: 10886676
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
Adewale AS; Macarthur H; Westfall TC
Neuropharmacology; 2007 May; 52(6):1396-402. PubMed ID: 17382974
[TBL] [Abstract][Full Text] [Related]
13. Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.
Fendt M; Bürki H; Imobersteg S; Lingenhöhl K; McAllister KH; Orain D; Uzunov DP; Chaperon F
Psychopharmacology (Berl); 2009 Oct; 206(2):291-301. PubMed ID: 19609506
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts.
Robidoux J; Simoneau L; St-Pierre S; Masse A; Lafond J
Endocrinology; 2000 Aug; 141(8):2795-804. PubMed ID: 10919265
[TBL] [Abstract][Full Text] [Related]
15. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
Redrobe JP; Dumont Y; Fournier A; Quirion R
Neuropsychopharmacology; 2002 May; 26(5):615-24. PubMed ID: 11927186
[TBL] [Abstract][Full Text] [Related]
16. Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.
Malmström RE
Br J Pharmacol; 2001 Aug; 133(7):1073-80. PubMed ID: 11487518
[TBL] [Abstract][Full Text] [Related]
17. Valence-dependent effects of neuropeptide Y on the expression of conditioned fear and anxiety-like behavior: Involvement of the bed nucleus of the stria terminalis.
Kornhuber J; Zoicas I
Neuropharmacology; 2024 Mar; 246():109847. PubMed ID: 38218578
[TBL] [Abstract][Full Text] [Related]
18. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
19. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
Rimondini R; Thorsell A; Heilig M
Neurosci Lett; 2005 Feb; 375(2):129-33. PubMed ID: 15670655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
